| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FBXW7_0008500 | Exon-Intron | chr4:153332455-153372928 | chr4:152411303-152451776 | 126 nt | 0.4524 |
| hsa_FBXW7_0007300 | Exon-Intron | chr4:153332455-153372932 | chr4:152411303-152451780 | 250 nt | 0.3960 |
| hsa_FBXW7_0007400 | Exon-Intron | chr4:153332455-153393050 | chr4:152411303-152471898 | 250 nt | 0.3880 |
| hsa_FBXW7_0008600 | Exon-Intron | chr4:153332455-153396997 | chr4:152411303-152475845 | 188 nt | 0.3777 |
| hsa_FBXW7_0008700 | Exon-Intron | chr4:153332455-153403586 | chr4:152411303-152482434 | 65 nt | 0.3385 |
| hsa_FBXW7_0007500 | Exon-Intron | chr4:153332455-153429214 | chr4:152411303-152508062 | 250 nt | 0.3960 |
| hsa_FBXW7_0007600 | Exon-Intron | chr4:153332455-153445487 | chr4:152411303-152524335 | 250 nt | 0.3520 |
| hsa_FBXW7_0008900 | Exon-Exon | chr4:153332698-153333667 | chr4:152411546-152412515 | 36 nt | 0.5000 |
| hsa_chr4_0190800 | Intergenic-Intergenic | chr4:153332760-153456355 | chr4:152411608-152535203 | 485 nt | 0.5216 |
| hsa_FBXW7_0009000 | Exon-Exon | chr4:153332848-153332985 | chr4:152411696-152411833 | 138 nt | 0.4928 |
A study in human brain cancer demonstrated that the circFBXW7 functions as a tumor suppressor, where its expression inhibits cell progression, migration, and tumor formation [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. Further research confirmed its coding potential, showing the translated peptide FBXW7-185aa reduces the half-life of c-Myc and inhibits cell cycle progression [Sema Misir et al. DOI:10.1038/s41418-022-00948-7]. The peptide FBXW7-185aa, which originates from the circFBXW7, inhibits cell cycle progression [Misir et al. DOI:10.1038/s41418-022-00948-7].